11.8.2026 17:38:35 CEST | Demant A/S |
Investor Nyheder
Investor news
11. august 2026
Demant-ejede Oticon annoncerer lancering af nye premium-høreapparater
Lancering af Oticon Reveal™ med verdens første Dual AI-lydbehandlingsteknologi i et kompakt miniRITE-høreapparat baseret på den nye Reveal AI-teknologiplatform
Introduktion af næste generations-teknologi til forebyggelse af feedback samt en ny connectivity-platform
De nye produkter frigives i Q3 på alle større markeder
Demants øvrige høreapparatbrands udruller nye premium-høreapparater i løbet af H2 2026
Demant, som er en førende global høresundhedskoncern, annoncerer i dag lanceringen af Oticons nye genopladelige premium-høreapparat, Oticon Reveal. Det nye produkt, som bygger på Oticons BrainHearing™-filosofi og indeholder tredjegenerations AI-lydbehandlingssystem baseret på den nye Reveal AI™-høreapparatplatform, repræsenterer endnu et stort skridt fremad inden for høreapparatteknologi. Oticon Reveal er det første høreapparat, der kombinerer to dedikerede AI-systemer til lydbehandling, ét til tale og ét til kontekstuelle lyde, i et lille og kompakt design. Produktet vil i første omgang blive tilgængeligt i august 2026 og vil blive lanceret i alle fire prispunkter på alle større markeder i løbet af Q3.
“For Demant har innovation altid handlet om at udvikle høreteknologi, der forbedrer livet for mennesker med høretab. Med vores nye innovative høreapparat, Oticon Reveal, tager vi nu endnu et ambitiøst skridt ved at kombinere yderligere forbedringer af AI-lydbehandling med en dybere forståelse for, hvordan den menneskelige hjerne opfatter lyd. På den måde bringer vi brugerne tættere på at opleve naturlig hørelse end nogensinde før. Vi er stolte over at kunne tilbyde dette banebrydende produkt i et kompakt og kraftfuldt design, der understøtter stabil hørelse hele dagen,” siger Søren Nielsen, koncernchef & adm. direktør for Demant.
Verdens første Dual AI-system
Oticons seneste forskning inden for BrainHearing viser, at hjernen arbejder bedre, når den har adgang til det komplette lydbillede, som omfatter både tale og lyde fra omgivelserne. Oticon Reveal anvender derfor to dedikerede AI-systemer, der arbejder sammen i realtid: ét til at forstærke lyden af tale og ét til at bevare den samlede lytteoplevelse i det rigtige forhold, hvilket skaber en mere klar og naturlig høreoplevelse. Som følge heraf leverer Oticon Reveal 60 % kraftigere hjernerespons end Oticons tidligere premium-produkt, Oticon Intent™. Dette gør det muligt for brugerne at opleve en mere naturlig hørelse med et diskret høreapparat, der på en enkelt opladning har strøm nok til en hel dags AI-understøttet lydbehandling.
Industriførende håndtering af feedback
For at udnytte fordelene ved Dual AI fuldt ud er Oticon Reveal designet til at levere klar og stabil forstærket lyd hele dagen. Det forbedrede feedbacksystem håndterer løbende den lyd, som høreapparaterne leverer, og hjælper brugerne med at opfange vigtige taledetaljer med større klarhed. Denne unikke teknologi muliggør meget hurtig og præcis AI-lydbehandling og forebygger feedback. Teknologien er 30 % hurtigere og har fire gange større tilpasningsstabilitet end tidligere Oticon-teknologi, samtidig med at teknologien understøtter en naturlig og komfortabel lytteoplevelse.
En ny æra inden for connectivity
For at give brugerne en bedre lytteoplevelse i hverdagen kommer Oticon Reveal også med en ny connectivity-platform med forbedret signalstyrke, som giver mere stabil streaming og længere rækkevidde. Dette giver brugerne større bevægelsesfrihed, samtidig med at de kan foretage håndfrie opkald og streame lyd. Oticon Reveal, som er et Made for iPhone-høreapparat og er optimeret til Android™, tilbyder kompromisløs connectivity via Bluetooth® LE Audio og Auracast™-lydteknologi, hvilket giver brugeren mere stabil og problemfri connectivity.
En komplet produktportefølje
Ud over Oticon Reveal introducerer Oticon også et nyt CROS-apparat, som hjælper brugere med ensidig døvhed, og som vil styrke Oticons portefølje yderligere og adressere endnu flere brugerbehov. Sammen med Oticon Reveal og Oticon Zeal vil CROS RE blive en del af en industriførende portefølje med premium-løsninger til forskellige typer høretab og brugerbehov.
For yderligere information henviser vi til pressemeddelelsen fra Oticon her, der er tilgængelig fra 11. august.
Yderligere information:
Søren Nielsen, koncernchef & adm. direktør
Telefon +45 3917 7300
www.demant.com
Øvrige kontaktpersoner:
René Schneider, CFO
Peter Pudselykke, Head of Investor Relations
Gustav Høegh, Investor Relations Officer
Maribel Fransisco Alonso, Communication Manager
Kontakter
Maribel Alonso Francisco, Communication Manager, +45 3171 9261, msbl@demant.com
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 26,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.
Vedhæftninger
Investor news – Demant-ejede Oticon annoncerer lancering af nye premium-høreapparater.pdf
11.8.2026 17:38:35 CEST | Demant A/S |
Investor News
Investor news
11 August 2026
Demant-owned Oticon announces launch of new flagship hearing aids
Release of Oticon Reveal™, offering the world’s first Dual AI sound processing system in a compact miniRITE hearing aid format and based on the new Reveal AI technology platform
Introduction of next-generation feedback prevention technology and a new connectivity platform
Release of products in Q3 across all major markets
Rollout of new flagship hearing aids in Demant’s other hearing aid brands during H2 2026
Today, Demant, a global leader in hearing healthcare, announces the launch of Oticon’s new premium rechargeable hearing aid, Oticon Reveal. This introduction represents another leap forward in hearing aid technology, building on Oticon’s BrainHearing™ philosophy, including the third-generation AI-powered sound processing system based on the new Reveal AI™ hearing aid platform. Oticon Reveal is the first hearing aid to combine two dedicated AI systems for sound processing, one for speech and one for contextual sounds, in a small and compact form factor. The product will initially become available in August 2026 and will be launched in all four price points across all major markets during Q3.
“Innovation has always been about advancing hearing technology to improve the lives of people living with a hearing loss. With our new innovative hearing aid, Oticon Reveal, we are now taking another significant step towards this vision by combining further advancements in AI sound processing with a deeper understanding of how the human brain processes sound. That way, we are bringing users closer than ever to natural hearing. We are proud to offer this breakthrough solution in a compact, powerful design, supporting confident hearing throughout the entire day,” says Søren Nielsen, President & CEO of Demant.
The world’s first Dual AI system
Oticon’s latest BrainHearing research shows that the brain performs better when it has access to the full sound picture, which includes both speech and the contextual sounds around it. Oticon Reveal thus uses two dedicated AI systems, running in real time: one to enhance speech and one to preserve listening context in the right proportions, creating a clearer and more natural hearing experience. As a result, Oticon Reveal delivers a 60% stronger brain response than Oticon Intent. This allows users to experience more natural hearing in a discreet hearing aid with enough power for a full day of AI-enabled performance on a single charge.
Industry-leading feedback management
To fully realise the benefits of Dual AI, Oticon Reveal is designed to provide clear and stable amplified sound throughout the day. The improved feedback prevention technology continuously manages the sound delivered by the hearing aid, helping users access important speech details with greater clarity. This unique technology enables very fast and precise AI sound processing, delivering feedback prevention that is 30% faster and has four times the fitting precision of previous Oticon technology, while supporting a natural and comfortable listening experience.
A new era of connectivity
To give users a richer everyday experience, Oticon Reveal also introduces a new connectivity platform that offers enhanced signal strength, providing stabler streaming and a longer range. This allows users to move more freely, while taking hands-free calls and streaming audio. As a Made for iPhone and optimised for Android™ hearing aid, it offers uncompromising connectivity for a seamless experience through Bluetooth® LE Audio and Auracast™ broadcast technology.
A full portfolio
In addition to Oticon Reveal, Oticon is also introducing a new CROS device to aid users with single-sided deafness, which will further strengthen its portfolio and offering to support even more user needs. Together with Oticon Reveal and Oticon Zeal, CROS RE will become part of an industry-leading premium portfolio of solutions that caters for every hearing loss.
For further information, please find the press release from Oticon here, which is available from 11 August.
Further information:
Søren Nielsen, President & CEO
Phone +45 3917 7300
www.demant.com
Other contacts:
René Schneider, CFO
Peter Pudselykke, Head of Investor Relations
Gustav Høegh, Investor Relations Officer
Maribel Fransisco Alonso, Communication Manager
Contacts
Maribel Alonso Francisco, Communication Manager, +45 3171 9261, msbl@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 26,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.
Attachments
Investor news – Demant-owned Oticon announces launch of new flagship hearing aids.pdf
